FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3206433675> ?p ?o ?g. }

• W3206433675 endingPage "e27510" @default.
• W3206433675 startingPage "e27510" @default.
• W3206433675 abstract "Abstract Background: Infliximab (IFX) and adalimumab (ADA) refer to the classic drugs to treat moderate-severe inflammatory bowel disease (IBD), which have been proven to be effective to control IBD. However, the side effects exerted by IFX and ADA should be monitored in therapies, especially the paradoxical reaction of the skin system (e.g., psoriasis). Psoriasis is recognized as the most common skin lesion, capable of significantly affecting the quality of patients’ life. Methods: This study searched literatures published in English language with the qualifications on PubMed, Embase, Web of Science, Google, and Geenmedical databases. Over 2 co-authors assessed the quality of the articles and extracted the data independently. The data acquired were statistically analyzed with the statistical software of Revman and Stata. Results: The ADA Group achieved a higher incidence of psoriasis (odds ratio [OR] = 0.658, 95% confidence interval [CI] [0.471–0.919]); Females achieved a higher incidence of psoriasis than males (OR = 1.941, 95%CI [1.326–2.843], P < .05); Smoking up-regulated the incidence of psoriasis (OR = 1.679, 95%CI [1.237–2.279], P < .05); The interval of medication was over 1 year, and the interval of medication applying IFX was longer than that of the ADA Group; most cases could be relieved by using local hormone, phototherapy, or systemic hormone therapy under the strategy of biological agents. Conclusions: The frequency of reported in IBD exceeds those of other autoimmune diseases, and the ADA treatment for IBD is safer than IFX. Psoriasis is more common in females than in males. Smoking refers to one of risk factors of psoriasis." @default.
• W3206433675 created "2021-10-25" @default.
• W3206433675 creator A5004884157 @default.
• W3206433675 creator A5018429041 @default.
• W3206433675 creator A5031796791 @default.
• W3206433675 creator A5041243214 @default.
• W3206433675 creator A5065243448 @default.
• W3206433675 date "2021-10-22" @default.
• W3206433675 modified "2023-10-14" @default.
• W3206433675 title "The incidence of psoriasis among smokers and/or former smokers inflammatory bowel diseases patients treated with tumor necrosis factor antagonist" @default.
• W3206433675 cites W1482448048 @default.
• W3206433675 cites W1530534806 @default.
• W3206433675 cites W1550891575 @default.
• W3206433675 cites W1965428524 @default.
• W3206433675 cites W1969629625 @default.
• W3206433675 cites W1972811610 @default.
• W3206433675 cites W1997106678 @default.
• W3206433675 cites W2003391401 @default.
• W3206433675 cites W2007533329 @default.
• W3206433675 cites W2066676281 @default.
• W3206433675 cites W2068012094 @default.
• W3206433675 cites W2079288309 @default.
• W3206433675 cites W2120291004 @default.
• W3206433675 cites W2156818981 @default.
• W3206433675 cites W2168016399 @default.
• W3206433675 cites W2215920766 @default.
• W3206433675 cites W2224147671 @default.
• W3206433675 cites W2323476684 @default.
• W3206433675 cites W2328031395 @default.
• W3206433675 cites W2328123966 @default.
• W3206433675 cites W2334882509 @default.
• W3206433675 cites W2336670564 @default.
• W3206433675 cites W2469385630 @default.
• W3206433675 cites W2511973735 @default.
• W3206433675 cites W2588890764 @default.
• W3206433675 cites W2590661950 @default.
• W3206433675 cites W2609054181 @default.
• W3206433675 cites W2752721387 @default.
• W3206433675 cites W2753413920 @default.
• W3206433675 cites W2767888658 @default.
• W3206433675 cites W2771335117 @default.
• W3206433675 cites W2773675631 @default.
• W3206433675 cites W2780179719 @default.
• W3206433675 cites W2783494524 @default.
• W3206433675 cites W2784820212 @default.
• W3206433675 cites W2801276728 @default.
• W3206433675 cites W2802424903 @default.
• W3206433675 cites W2807097568 @default.
• W3206433675 cites W2901619209 @default.
• W3206433675 cites W2903869333 @default.
• W3206433675 cites W2904180906 @default.
• W3206433675 cites W2929064969 @default.
• W3206433675 cites W2951422171 @default.
• W3206433675 cites W2970968550 @default.
• W3206433675 cites W835669005 @default.
• W3206433675 doi "https://doi.org/10.1097/md.0000000000027510" @default.
• W3206433675 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8542134" @default.
• W3206433675 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34678884" @default.
• W3206433675 hasPublicationYear "2021" @default.
• W3206433675 type Work @default.
• W3206433675 sameAs 3206433675 @default.
• W3206433675 citedByCount "3" @default.
• W3206433675 countsByYear W32064336752022 @default.
• W3206433675 countsByYear W32064336752023 @default.
• W3206433675 crossrefType "journal-article" @default.
• W3206433675 hasAuthorship W3206433675A5004884157 @default.
• W3206433675 hasAuthorship W3206433675A5018429041 @default.
• W3206433675 hasAuthorship W3206433675A5031796791 @default.
• W3206433675 hasAuthorship W3206433675A5041243214 @default.
• W3206433675 hasAuthorship W3206433675A5065243448 @default.
• W3206433675 hasBestOaLocation W32064336751 @default.
• W3206433675 hasConcept C120665830 @default.
• W3206433675 hasConcept C121332964 @default.
• W3206433675 hasConcept C126322002 @default.
• W3206433675 hasConcept C141071460 @default.
• W3206433675 hasConcept C156957248 @default.
• W3206433675 hasConcept C16005928 @default.
• W3206433675 hasConcept C2777138892 @default.
• W3206433675 hasConcept C2778260677 @default.
• W3206433675 hasConcept C2778975655 @default.
• W3206433675 hasConcept C2779134260 @default.
• W3206433675 hasConcept C2780132546 @default.
• W3206433675 hasConcept C2780479503 @default.
• W3206433675 hasConcept C2780564577 @default.
• W3206433675 hasConcept C44249647 @default.
• W3206433675 hasConcept C61511704 @default.
• W3206433675 hasConcept C71924100 @default.
• W3206433675 hasConcept C90924648 @default.
• W3206433675 hasConceptScore W3206433675C120665830 @default.
• W3206433675 hasConceptScore W3206433675C121332964 @default.
• W3206433675 hasConceptScore W3206433675C126322002 @default.
• W3206433675 hasConceptScore W3206433675C141071460 @default.
• W3206433675 hasConceptScore W3206433675C156957248 @default.
• W3206433675 hasConceptScore W3206433675C16005928 @default.
• W3206433675 hasConceptScore W3206433675C2777138892 @default.
• W3206433675 hasConceptScore W3206433675C2778260677 @default.
• W3206433675 hasConceptScore W3206433675C2778975655 @default.
• W3206433675 hasConceptScore W3206433675C2779134260 @default.

• next